Overwhelming fatal infection in a young woman after intravenous cyclophosphamide therapy for lupus nephritis.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 1823528.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We describe the case of a 19-year-old woman who died of overwhelming aspergillosis 3 months after receiving intravenous (IV) cyclophosphamide for progressive lupus nephritis. Her history is instructive because it illustrates the wisdom of strict adherence to the National Institutes of Health protocol for this treatment, specifically, the contraindication to use of IV cyclophosphamide when other immunosuppressive therapy has recently been employed.
Medical subject headings
- Cyclophosphamide
- Infections
- Lupus Nephritis